Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 55% ± 13% | |
lung | 19 studies | 64% ± 16% | |
brain | 18 studies | 42% ± 15% | |
intestine | 11 studies | 56% ± 15% | |
eye | 10 studies | 41% ± 18% | |
kidney | 9 studies | 64% ± 10% | |
liver | 7 studies | 57% ± 15% | |
lymph node | 6 studies | 56% ± 22% | |
bone marrow | 6 studies | 46% ± 15% | |
pancreas | 5 studies | 74% ± 24% | |
uterus | 5 studies | 67% ± 16% | |
prostate | 5 studies | 56% ± 14% | |
placenta | 4 studies | 72% ± 28% | |
heart | 4 studies | 28% ± 8% | |
adipose | 4 studies | 38% ± 10% | |
esophagus | 4 studies | 49% ± 26% | |
breast | 4 studies | 69% ± 6% | |
adrenal gland | 3 studies | 57% ± 7% | |
skin | 3 studies | 44% ± 8% | |
thymus | 3 studies | 61% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 33152.70 | 459 / 459 | 100% | 720.04 | 1118 / 1118 |
esophagus | 100% | 28772.04 | 1445 / 1445 | 100% | 506.30 | 183 / 183 |
intestine | 100% | 32469.88 | 966 / 966 | 100% | 542.52 | 527 / 527 |
kidney | 100% | 40483.46 | 89 / 89 | 100% | 700.42 | 901 / 901 |
liver | 100% | 58775.12 | 226 / 226 | 100% | 606.51 | 406 / 406 |
lung | 100% | 37006.97 | 578 / 578 | 100% | 529.60 | 1155 / 1155 |
ovary | 100% | 25174.68 | 180 / 180 | 100% | 524.63 | 430 / 430 |
pancreas | 100% | 21974.14 | 328 / 328 | 100% | 470.60 | 178 / 178 |
prostate | 100% | 27644.25 | 245 / 245 | 100% | 663.83 | 502 / 502 |
stomach | 100% | 35782.87 | 359 / 359 | 100% | 528.60 | 286 / 286 |
uterus | 100% | 24812.47 | 170 / 170 | 100% | 437.12 | 459 / 459 |
brain | 100% | 25769.34 | 2641 / 2642 | 100% | 570.79 | 704 / 705 |
thymus | 100% | 41034.68 | 653 / 653 | 100% | 643.11 | 603 / 605 |
bladder | 100% | 29765.38 | 21 / 21 | 100% | 508.13 | 502 / 504 |
skin | 100% | 30485.60 | 1809 / 1809 | 100% | 352.55 | 470 / 472 |
adrenal gland | 100% | 45734.74 | 258 / 258 | 99% | 372.81 | 227 / 230 |
adipose | 100% | 32266.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 317.40 | 29 / 29 |
spleen | 100% | 25793.00 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 403.90 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 197.03 | 1 / 1 |
blood vessel | 100% | 25659.27 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 16499.87 | 801 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 33184.77 | 919 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 15191.84 | 846 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 248.65 | 78 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0033119 | Biological process | negative regulation of RNA splicing |
GO_0034620 | Biological process | cellular response to unfolded protein |
GO_1902236 | Biological process | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
GO_0036483 | Biological process | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
GO_0002638 | Biological process | negative regulation of immunoglobulin production |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_2001234 | Biological process | negative regulation of apoptotic signaling pathway |
GO_0060702 | Biological process | negative regulation of endoribonuclease activity |
GO_0006914 | Biological process | autophagy |
GO_0032091 | Biological process | negative regulation of protein binding |
GO_1903298 | Biological process | negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway |
GO_1902065 | Biological process | response to L-glutamate |
GO_0032469 | Biological process | endoplasmic reticulum calcium ion homeostasis |
GO_0010523 | Biological process | negative regulation of calcium ion transport into cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0060698 | Molecular function | endoribonuclease inhibitor activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TMBIM6 |
Protein name | Bax inhibitor 1 (Testis-enhanced gene transcript protein) (Transmembrane BAX inhibitor motif-containing protein 6) Transmembrane BAX inhibitor motif containing 6 Bax inhibitor 1 (BI-1) (Testis-enhanced gene transcript protein) (Transmembrane BAX inhibitor motif-containing protein 6) |
Synonyms | TEGT BI1 |
Description | FUNCTION: Suppressor of apoptosis . Modulates unfolded protein response signaling . Modulates ER calcium homeostasis by acting as a calcium-leak channel . Negatively regulates autophagy and autophagosome formation, especially during periods of nutrient deprivation, and reduces cell survival during starvation (By similarity). . |
Accessions | F8W1V3 ENST00000267115.10 [P55061-1] ENST00000550951.5 F8VQW0 ENST00000551154.5 ENST00000548809.5 F8VQQ5 ENST00000548894.5 ENST00000552635.5 A0A0G2JKZ4 ENST00000549445.5 F8VVJ4 ENST00000549966.5 F8W201 ENST00000552370.5 [P55061-1] ENST00000549385.5 [P55061-1] ENST00000548201.5 ENST00000550445.5 ENST00000546796.5 ENST00000423828.5 [P55061-2] ENST00000395006.8 [P55061-1] F8W086 ENST00000549130.5 ENST00000547832.5 F8VPI1 ENST00000548713.5 ENST00000547187.5 F8W1G3 ENST00000546914.5 ENST00000552699.5 [P55061-2] P55061 F8VSI7 F8VR05 F8VX73 F8VY06 ENST00000547798.1 |